The Medicines & Healthcare products Regulatory Agency (MHRA) is working closely with the Government to analyse the best options and opportunities available for the safe and effective regulation of medicines and medical devices in the UK.
The theme of the 12th annual Business of Regenerative Medicine conference at Harvard Business School is Defining and Creating Value.
This four-day course covers issues in regulatory science for gene and cell-therapy medicinal products.
Bringing together pioneers and policy-makers, innovators and implementers to discuss how developments in genomics, AI and digital are transforming our ability to predict and manage disease, and how policy can help move us from vision to reality in healthcare.
Join this webinar to get practical hints and tips on the different areas to consider when preparing for GMP manufacture of ATMPs. CGT Catapult subject matter experts will be drawing on their own expertise and their experience of collaborating with therapy developers at the CGT Catapult manufacturing centre.
BSGCT's Annual Conference in 2019 takes place from 19th-21st June in Sheffield. The conference brings together scientists from across the UK and beyond to highlight the latest research and techniques in gene and cell therapy.
The BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO), which represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations.
We are attending ISCT 2019 in collaboration with the UK’s National Institute for Health and Care Excellence (NICE) to meet cell and gene therapy experts with an interest in the UK ATMP ecosystem.